AI assistant
IDEXX LABORATORIES INC /DE — Director's Dealing 2021
Feb 17, 2021
30016_dirs_2021-02-17_8384718e-ce1a-429d-8ad9-7ca7b04cae70.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IDEXX LABORATORIES INC /DE (IDXX)
CIK: 0000874716
Period of Report: 2021-02-14
Reporting Person: MCKEON BRIAN P (Executive VP & CFO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-02-14 | Common Stock | M | 810 | — | Acquired | 25524 | Direct |
| 2021-02-14 | Common Stock | M | 459 | — | Acquired | 25983 | Direct |
| 2021-02-14 | Common Stock | M | 505 | — | Acquired | 26488 | Direct |
| 2021-02-14 | Common Stock | M | 435 | — | Acquired | 26923 | Direct |
| 2021-02-14 | Common Stock | M | 433 | — | Acquired | 27356 | Direct |
| 2021-02-14 | Common Stock | F | 1335 | $544.08 | Disposed | 26021 | Direct |
| 2021-02-16 | Common Stock | S | 1307 | $539.58 | Disposed | 24714 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-02-14 | Non-Qualified Stock Option (right-to-buy) | $544.08 | A | 9538 | Acquired | 2031-02-13 | Common Stock (9538) | Direct |
| 2021-02-14 | Incentive Stock Option (right-to-buy) | $544.08 | A | 183 | Acquired | 2021-02-13 | Common Stock (183) | Direct |
| 2021-02-14 | Restricted Stock Unit | $ | A | 1011 | Acquired | Common Stock (1011) | Direct | |
| 2021-02-14 | Restricted Stock Unit | $ | M | 810 | Disposed | Common Stock (810) | Direct | |
| 2021-02-14 | Restricted Stock Unit | $ | M | 459 | Disposed | Common Stock (459) | Direct | |
| 2021-02-14 | Restricted Stock Unit | $ | M | 505 | Disposed | Common Stock (505) | Direct | |
| 2021-02-14 | Restricted Stock Unit | $ | M | 435 | Disposed | Common Stock (435) | Direct | |
| 2021-02-14 | Restricted Stock Unit | $ | M | 433 | Disposed | Common Stock (433) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 18050 | Indirect |
Footnotes
F1: Includes 14 shares purchased under the Issuer's Employee Stock Purchase Plan on December 31, 2020.
F2: Closing price of Issuer common stock on the NASDAQ Global Select Market on February 12, 2021.
F3: Grant of option to buy shares of Issuer common stock that becomes exercisable in four annual installments beginning February 14, 2022.
F4: Grant of option to buy shares of Issuer common stock that becomes exercisable in one installment on the fourth anniversary of the date of grant.
F5: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2022.
F6: Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vested in five annual installments, beginning February 14, 2017.
F7: Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five annual installments, beginning February 14, 2018.
F8: Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five annual installments, beginning February 14, 2019.
F9: Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five annual installments, beginning February 14, 2020.
F10: Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2021.
F11: Not applicable.